The similarities in practice between cardiovascular medicine and vascular surgery
are impossible to ignore. The disease processes, the patient population, and the approach
to treatment have continued to converge since the report of the first coronary angiography.
1
In both specialties, pushing the limits of novel techniques for intervention has
meant that our understanding of cardiovascular disease has evolved and our thought
processes and approaches have been refined. And now, as the burden of cardiovascular
disease increases globally,
2
it is our responsibility as cardiovascular specialists to recognise the synergies
and build a system that puts patients at the centre of the care team. What better
time than the announcement of the 2022 Canadian Cardiovascular Society (CCS) peripheral
artery disease (PAD) guidelines to highlight this common ground. The PAD guidelines
are a monumental document from the CCS members and vascular specialists to guide care
of PAD patients in Canada.
3
It is the aspiration of these guidelines that at every point of contact, PAD patients
are offered optimal diagnostics and receive the best medical management, and interventionalists
are guided by the latest evidence.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Percutaneous transluminal coronary angioplasty.Seminars in Roentgenology. 1981; 16: 152-153
- Global burden of cardiovascular diseases and risk factors, 1990-2019.J Am Coll Cardiol. 2020; 76: 2982-3021
- Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease.Can J Cardiol. 2022; 38: 560-587
- Diet and nutrition in peripheral artery disease: a systematic review.Can J Cardiol. 2022; 38: 672-680
- Prehabilitation for vascular surgery patients: challenges and opportunities.Can J Cardiol. 2022; 38: 645-653
- Diagnostic and therapeutic challenges of vasculitis.Can J Cardiol. 2022; 38: 623-633
- Inflammation as a mechanism and therapeutic target in peripheral artery disease.Can J Cardiol. 2022; 38: 588-600
- Building your peripheral artery disease toolkit: medical management of peripheral artery disease in 2022.Can J Cardiol. 2022; 38: 634-644
- Antithrombotic therapy in peripheral arterial disease: risk stratification and clinical decision making.Can J Cardiol. 2022; 38: 654-661
- Challenges in peripheral artery disease clinical trial implementation and design.Can J Cardiol. 2022; 38: 699-702
- Updates in endovascular procedural navigation.Can J Cardiol. 2022; 38: 662-671
- Who to screen for thoracic aortic aneurysms, and when to refer for surgery.Can J Cardiol. 2022; 38: 695-698
- Sex as a key determinant of peripheral artery disease: epidemiology, differential outcomes, and proposed biological mechanisms.Can J Cardiol. 2022; 38: 601-611
- Social deprivation and peripheral artery disease.Can J Cardiol. 2022; 38: 612-622
Article info
Publication history
Published online: March 25, 2022
Accepted:
March 23,
2022
Received:
March 11,
2022
Footnotes
See page 554 for disclosure information.
Identification
Copyright
© 2022 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
